Novanta Inc. Common Stock (NOVT) — 分析摘要
Novanta Inc. Common Stock（NOVT）的市值为5.22十亿美元，最近一年的营收同比增长了+3.3%。净利润率为5.5%。当前市盈率为97.2倍。
核心要点
- 营收同比变化+3.3%
- 净利润率5.5%
- 市盈率97.2倍
与MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES板块的其他公司相比，NOVT的营收增长为+3.3%，市盈率为97.2倍。
Novanta Inc. Common Stock (NOVT)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报，没有触发重大的信用、利润率或趋势红旗。
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
行业
MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES
员工人数
3,000
总部
BEDFORD, MA
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。